Grants & Programs

Regulatory Guidance

The Consortium facilitates dialog with regulatory bodies, such as the U.S. Food and Drug Administration, in order to provide a comprehensive understanding of the regulatory climate and help develop needed standards for evaluating cancer immunotherapies. Member-only workshops and working groups aim to provide comments on guidelines released by regulatory agencies.


Become a member

Are you interested in becoming part of the Cancer Immunotherapy Consortium?

Join Now

Contact Us

Want to learn more about the Cancer Immunotherapy Consortium? Contact a CIC representative at or (212) 688-7515.